I also bought in (again) yesterday at $2:41.
I've taken a small but helpful profit on 2 short term trades in the last 2 months.
I feel the result was good, the dividend made sense (in hindsight), Tropicana is going to turn out to be a masterstroke, and the share price has been beaten down to around this level 4 times in the last 2 months.
I *think* a break below this level is unlikely, but in saying that I don't have a stop in place because if it was to go down to $2.20 and $2, I would be buying more at those levels.
I am looking for $3 by the end of the year. I think Tropicana will delight.
I am also excited by McPhillamys.
Although the company is being asked to jump through hoops for the approvals process, I think there is a pretty good chance it will get "State Significant Project" status once it is finally approved - https://www.planningportal.nsw.gov.au/major-projects
I am confident we will be back above $6.50 (all time highs) within 3 years, and I am hoping for $0.25c (4%) dividends, which is 10% on today's prices.
- Forums
- ASX - By Stock
- RRL
- Under valued
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

Under valued, page-129
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 4.350 |
4 | 7325 | 4.300 |
1 | 1174 | 4.270 |
2 | 1435 | 4.250 |
1 | 2700 | 4.240 |
Price($) | Vol. | No. |
---|---|---|
4.420 | 5266 | 1 |
4.550 | 1000 | 1 |
4.570 | 222 | 1 |
4.580 | 6000 | 1 |
4.610 | 180 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online